Progress in the Development of Synthetic Thrombin Inhibitors as New Orally Active Anticoagulants

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|17|2297-2321

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.17, 2004-09, pp. : 2297-2321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Oral Anticoagulants for Venous Thromboembolism: Focus on Factor Xa and Thrombin Inhibitors

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

New Parenteral Anticoagulants: Focus on Factor Xa and Thrombin Inhibitors

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 129-136

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the development of thrombin inhibitors

By Steinmetzer T.   Hauptmann J.   Stürzebecher J.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 845-864

Informa Healthcare

Access to resources Recommend Favorite

G-Quadruplex Aptamers to Human Thrombin Versus Other Direct Thrombin Inhibitors: The Focus on Mechanism of Action and Drug Efficiency as Anticoagulants

By  

Current Medicinal Chemistry, Vol. 23, Iss. 21, 2016-08 ,pp. : 2230-2244

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Matrix Metalloproteinase Inhibitors

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1388-1395

Bentham Science Publishers

Access to resources Recommend Favorite